Global

COVID vaccine protects against symptoms 6 weeks after infection-- study

Thu, 2024-09-26 10:09 — mike kraft

COVID vaccine protects against symptoms 6 weeks after infection, study shows If the third vaccine dose was administered 16 weeks or less before infection, healthcare providers had lower odds of reporting respiratory symptoms. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about COVID vaccine protects against symptoms 6 weeks after infection-- study
Log in or register to post comments

Cognitive Impacts of COVID Equivalent to 20 Years of Brain Aging--British study

Wed, 2024-09-25 10:10 — mike kraft

Cognitive Impacts of COVID Equivalent to 20 Years of Brain Aging - Neuroscience News A new study reveals that 12-18 months after hospitalization for COVID-19, patients show significant cognitive decline comparable to 20 years of aging. Neuroscience News Neuroscience News

A new study reveals that 12-18 months after hospitalization for COVID-19, patients show significant cognitive decline comparable to 20 years of aging. MRI scans and blood tests also show brain injury markers and reduced brain volume in these patients. The findings suggest that COVID-19 has lasting effects on brain health, even in those without neurological complications.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Cognitive Impacts of COVID Equivalent to 20 Years of Brain Aging--British study
Log in or register to post comments

Kids born during COVID-19 pandemic don't have higher autism risk--study

Wed, 2024-09-25 10:02 — mike kraft

No increased risk of autism seen in pandemic-era children Children born during the first year of the COVID-19 pandemic—with or without exposure to maternal infections—do not seem to be at increased risk for developing autism, according to a new study in JAMA Network Open. CIDRAP

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Solutions

Read more about Kids born during COVID-19 pandemic don't have higher autism risk--study
Log in or register to post comments

Mosquito-born EEE: Declared threat in New York State; impact of climate change

Tue, 2024-09-24 10:09 — mike kraft

After New Yorker dies of EEE, state declares virus an "imminent threat to the public" The New York resident who tested positive for the mosquito-borne EEE virus has died, prompting state health officials to declare an "imminent threat to the public for EEE." CBS New York

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Mosquito-born EEE: Declared threat in New York State; impact of climate change
Log in or register to post comments

WHO to call for urgent, high-level action to address global problem of antimicrobial resistance

Fri, 2024-09-20 17:39 — mike kraft

WHO at UNGA: Call for urgent, high-level action to address global scourge of antimicrobial resistance The World Health Organization (WHO) and partners will call on world leaders to address critical global health challenges, and invest in global public health, at meetings throughout the high-level week of the 79th session of the United Nations General Assembly (UNGA79), to be held in New York from 20 to 30 September 2024.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about WHO to call for urgent, high-level action to address global problem of antimicrobial resistance
Log in or register to post comments

Common diabetes drug may lower rate of long COVID --study

Fri, 2024-09-20 10:36 — mike kraft

Common diabetes drug linked to lower rate of long COVID Metformin is the most common type 2 diabetes drug prescribed to millions of American each year, and a new study from researchers at the National Institutes of Health (NIH) published in Diabetes Care suggests the drug can lower the risk of developing long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), in diabetics. CIDRAP

...

Metformin lowers blood sugar and is most commonly prescribed as a first-line treatment for type 2 diabetes. The drug also is prescribed off-label for weight loss and other metabolic conditions.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Solutions

Read more about Common diabetes drug may lower rate of long COVID --study
Log in or register to post comments

Africa CDC warns Mpox is not under control in the continent

Fri, 2024-09-20 10:19 — mike kraft

Mpox is not under control in Africa, warns Africa CDC

DAKAR, Sept 19 (Reuters) - The mpox outbreak in Africa is still not under control, the Africa Centres for Disease Control and Prevention (Africa CDC) warned on Thursday, adding that cases were still increasing in several countries.

Country / Region Tags:

Africa

Democratic Republic of the Congo

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Africa CDC warns Mpox is not under control in the continent
Log in or register to post comments

Gavi to buy 500,000 mpox vaccine doses for Africa.

Thu, 2024-09-19 11:21 — mike kraft

Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Gavi to buy 500,000 mpox vaccine doses for Africa.
Log in or register to post comments

Climate change, conflict are undermining efforts to help world's poorest --Global Health Fund report

Thu, 2024-09-19 10:38 — mike kraft

Global health fund says health, climate, conflict 'triple whammy' hits world's poorest

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Climate change, conflict are undermining efforts to help world's poorest --Global Health Fund report
Log in or register to post comments

WHO's Global COVID-19 epidemiological update --new cases up in August

Thu, 2024-09-19 10:22 — mike kraft

COVID-19 epidemiological update – 17 September 2024 Edition 171

...

Globally, during the 28-day period (22 July to 18 August 2024), the number of new cases and deaths increased by 23% and 44% compared to the previous 28-day period (24 June to 18 August 2024), with 238 000 new cases reported across 91 (39%) countries and about 4400 new fatalities reported across 35 (15%) countries, respectively. As of 22 July to 18 August 2024, over 776 million confirmed cases and more than seven million deaths have been reported globally since the beginning of pandemic.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report